Decreased neonatal hepatitis B virus (HBV) viremia by maternal tenofovir treatment predicts reduced chronic HBV infection in children born to highly viremic mothers.

Saved in:
Bibliographic Details
Title: Decreased neonatal hepatitis B virus (HBV) viremia by maternal tenofovir treatment predicts reduced chronic HBV infection in children born to highly viremic mothers.
Authors: Chang KC; Taipei, Taiwan., Chang MH; Taipei, Taiwan., Lee CN; Taipei, Taiwan., Chang CH; Taipei, Taiwan., Wu JF; Taipei, Taiwan., Ni YH; Taipei, Taiwan., Wen WH; New Taipei City, Taiwan., Shyu MK; Taipei, Taiwan., Lai MW; Taoyuan, Taiwan., Chen SM; Taipei, Taiwan., Hu JJ; Taipei, Taiwan., Lin HH; New Taipei City, Taiwan., Hsu JJ; Taipei, Taiwan., Mu SC; Taipei, Taiwan., Lin YC; New Taipei City, Taiwan., Liu CJ; Taipei, Taiwan., Chen DS; Taipei, Taiwan., Lin LH; Taipei, Taiwan., Chen HL; Taipei, Taiwan.
Corporate Authors: Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV (PreMIT study)
Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2019 Aug; Vol. 50 (3), pp. 306-316. Date of Electronic Publication: 2019 Jul 04.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1365-2036
DOI:10.1111/apt.15321